Viatris | VTRS - Umsatzkosten

Aktienkurs
14.94
Täglich Wechseln
-0.03 -0.20%
Monatlich
10.58%
Jährlich
76.39%
Q2 Prognose
14.28




Umsatzkosten Veränderung Datum
Celltrion KRW 402.86B 14.24B 2025-09
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 10.63B 1.23B 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pharma Mar EUR 3.77M 1.47M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.56B 167.3M 2025-12
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03